Published in Auton Neurosci on March 16, 2013
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care (2010) 6.64
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol (2011) 3.53
Neural activity relating to generation and representation of galvanic skin conductance responses: a functional magnetic resonance imaging study. J Neurosci (2000) 3.49
Neural activity in the human brain relating to uncertainty and arousal during anticipation. Neuron (2001) 3.49
Contact-dependent inhibition of growth in Escherichia coli. Science (2005) 3.29
A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria. Nature (2010) 2.91
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol (1995) 2.76
The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain (2008) 2.74
Cerebral correlates of autonomic cardiovascular arousal: a functional neuroimaging investigation in humans. J Physiol (2000) 2.72
International standards to document remaining autonomic function after spinal cord injury. Spinal Cord (2008) 2.65
Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol (1990) 2.45
Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 2.42
Contact-dependent growth inhibition requires the essential outer membrane protein BamA (YaeT) as the receptor and the inner membrane transport protein AcrB. Mol Microbiol (2008) 2.27
Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology (2000) 2.19
Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry (1998) 2.19
Bacterial contact-dependent delivery systems. Annu Rev Genet (2010) 2.19
A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. J Nucl Med (1993) 2.06
Rhs proteins from diverse bacteria mediate intercellular competition. Proc Natl Acad Sci U S A (2013) 1.98
Identification of functional toxin/immunity genes linked to contact-dependent growth inhibition (CDI) and rearrangement hotspot (Rhs) systems. PLoS Genet (2011) 1.98
Skin biopsy in the management of peripheral neuropathy. Lancet Neurol (2007) 1.69
Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry (2001) 1.68
Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine. Lancet (1997) 1.65
Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM. J Nucl Med (2000) 1.65
Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci U S A (2004) 1.65
Skin blood flow and local temperature independently modify sweat rate during passive heat stress in humans. J Appl Physiol (1985) (2010) 1.64
Neuroanatomical basis for first- and second-order representations of bodily states. Nat Neurosci (2001) 1.61
IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann Neurol (2005) 1.56
The prevalence and association of neck (coat-hanger) pain and orthostatic (postural) hypotension in human spinal cord injury. Spinal Cord (2002) 1.55
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension (2011) 1.54
Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53
Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol (1993) 1.52
Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A (2012) 1.50
Organisation of the sympathetic skin response in spinal cord injury. J Neurol Neurosurg Psychiatry (2002) 1.49
Acute volume expansion preserves orthostatic tolerance during whole-body heat stress in humans. J Physiol (2009) 1.47
Autonomic neuropathies. Continuum (Minneap Minn) (2014) 1.44
Amyotrophic lateral sclerosis with mutation of the Cu/Zn superoxide dismutase gene (SOD1) in a patient with Down syndrome. Neuromuscul Disord (2007) 1.44
New autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet (1991) 1.43
The toxin/immunity network of Burkholderia pseudomallei contact-dependent growth inhibition (CDI) systems. Mol Microbiol (2012) 1.41
Cardiovascular, autonomic, and plasma catecholamine responses in unilateral and bilateral carotid artery stenosis. J Neurol Neurosurg Psychiatry (1999) 1.40
Clinical Autonomic Research in the 1990s. Clin Auton Res (1991) 1.39
Postural tachycardia syndrome--current experience and concepts. Nat Rev Neurol (2011) 1.38
EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol (2006) 1.37
Bacterial contact-dependent growth inhibition. Trends Microbiol (2013) 1.36
Unexplained syncope--is screening for carotid sinus hypersensitivity indicated in all patients aged >40 years? J Neurol Neurosurg Psychiatry (2006) 1.30
The mechanism by which DNA adenine methylase and PapI activate the pap epigenetic switch. Mol Cell (2003) 1.29
Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. Arch Neurol (2009) 1.29
Hemodynamic responses to heat stress in the resting and exercising human leg: insight into the effect of temperature on skeletal muscle blood flow. Am J Physiol Regul Integr Comp Physiol (2010) 1.27
Identification of a target cell permissive factor required for contact-dependent growth inhibition (CDI). Genes Dev (2012) 1.27
Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology (2002) 1.26
Sensory neuron diseases. Lancet Neurol (2005) 1.26
Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med (1975) 1.26
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Endogenous nitric oxide attenuates neutrally mediated cutaneous vasoconstriction. J Physiol (2007) 1.25
Programmed heterogeneity: epigenetic mechanisms in bacteria. J Biol Chem (2013) 1.25
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol (1992) 1.23
Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences. J Neurol Sci (2011) 1.23
Structural basis of toxicity and immunity in contact-dependent growth inhibition (CDI) systems. Proc Natl Acad Sci U S A (2012) 1.23
Autonomic disorders and their recognition. N Engl J Med (1997) 1.22
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology (2003) 1.22
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol (2008) 1.21
Mechanisms of reflex cardiac arrest in tetraplegic patients. Lancet (1975) 1.21
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21
Genetically distinct pathways guide effector export through the type VI secretion system. Mol Microbiol (2014) 1.20
Small-fibre neuropathies--advances in diagnosis, pathophysiology and management. Nat Rev Neurol (2012) 1.19
Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet (1978) 1.17
Receptor polymorphism restricts contact-dependent growth inhibition to members of the same species. MBio (2013) 1.16
Effects of graded heat stress on global left ventricular function and twist mechanics at rest and during exercise in healthy humans. Exp Physiol (2010) 1.16
Intravenous morphine causes hypertension, hyperglycaemia and increases sympatho-adrenal outflow in conscious rabbits. Clin Sci (Lond) (1988) 1.16
Autonomic failure preceding dementia with Lewy bodies. J Neurol (2000) 1.15
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin Cancer Res (2006) 1.15
Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human. J Physiol (2006) 1.14
A novel TRK A (NTRK1) mutation associated with hereditary sensory and autonomic neuropathy type V. Ann Neurol (2001) 1.14
Delivery of CdiA nuclease toxins into target cells during contact-dependent growth inhibition. PLoS One (2013) 1.13
Brain activity during biofeedback relaxation: a functional neuroimaging investigation. Brain (2001) 1.13
Regulation of the pap epigenetic switch by CpxAR: phosphorylated CpxR inhibits transition to the phase ON state by competition with Lrp. Mol Cell (2004) 1.12
The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) (1986) 1.11
Nitric oxide inhibits cutaneous vasoconstriction to exogenous norepinephrine. J Appl Physiol (1985) (2008) 1.11
Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic data. PLoS One (2013) 1.10
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain (2011) 1.09
Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension. J Hum Hypertens (1996) 1.08
Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry (2012) 1.07
Plasma and urinary dopamine: studies during fasting and exercise and in tetraplegic man. Eur J Clin Invest (1976) 1.07
Skin grafting impairs postsynaptic cutaneous vasodilator and sweating responses. J Burn Care Res (2007) 1.07
Signals of growth regulation in bacteria. Curr Opin Microbiol (2009) 1.06
Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Circ Res (1976) 1.06
Posterior reversible encephalopathy syndrome as the initial manifestation of Guillain-Barré syndrome: case report and review of the literature. J Peripher Nerv Syst (2012) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem (1996) 1.05
Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. J Physiol (1992) 1.04
Impaired cutaneous vasodilation and sweating in grafted skin during whole-body heating. J Burn Care Res (2007) 1.03
Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution. Br J Pharmacol (1989) 1.03
Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem (1997) 1.03
Enhanced pressor response to noradrenaline in patients with cervical spinal cord transection. Brain (1976) 1.02